RecruitingNCT07297394
Mechanisms of Maternal Immune Tolerance in Early Pregnancy
Sponsor
University Hospital, Basel, Switzerland
Enrollment
100 participants
Start Date
Mar 2, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This study explores the mechanisms of maternal immune tolerance in early pregnancy by characterizing immune cell profiles and functional pathways during the first trimester. The goal is to identify immunological factors that support healthy gestation and prevent complications such as miscarriages.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria3
- Blood from patients will be included before and during pregnancies (or failed implantation) conceived through IVF/ICSI (Intracytoplasmic Sperm Injection) treatment and in case of miscarriage.
- where the patient (pregnant person) was ≥ 18 years of age.
- where the patient (pregnant person) signed a written informed consent.
Exclusion Criteria2
- Certain maternal infections (HIV, Hepatitis B, Hepatitis C, Syphilis)
- Patients under immunosuppressive medications (at time of blood sample collection)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERBlood sampling
Blood samples will be analyzed before and during early pregnancy as well as after early miscarriage
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07297394
Related Trials
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
NCT061132372 locations
Automated Insulin for Management of Intrapartum Glycemia
NCT068833442 locations
Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management
NCT072248931 location
Pregnancy and Risk of Venous Thromboembolism
NCT036597081 location
Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients
NCT066700791 location